Photodynamic therapy of transitional cell carcinoma multicellular tumor spheroids with hypericin
- PMID: 14532989
Photodynamic therapy of transitional cell carcinoma multicellular tumor spheroids with hypericin
Abstract
The objective of the present study was to evaluate the sensitivity of the bladder transitional cell carcinoma (TCC) to hypericin PDT in a 3-D system using multicellular tumor spheroids. The photodynamic response in RT-112 human bladder TCC spheroids was also compared to 2-D cultured monolayer cells. Following a 2-4 h incubation with 8-30 microM hypericin, spheroids or monolayer cells were irradiated at the light dose of 12 J/cm2, delivered at a fluence rate of 10-100 mW/cm2. The PDT effects were evaluated using a clonogenic assay. The results show that compared with the cells in a monolayer, cells in spheroids were dramatically less sensitive to hypericin PDT (<2000-fold). Studies of fluorescence microphotographs of centrally cut frozen sections of hypericin-exposed spheroids showed a gradient in hypericin concentration from the peripheral to the central region of the spheroid. Although it can be suggested that heterogeneity of drug uptake might be responsible for the observed resistance of spheroid to hypericin PDT, hypericin sensitized spheroids that were dissociated prior to light irradiation were as sensitive as the monolayer cells to hypericin PDT, suggesting that other factors such as oxygen depletion might be responsible for the resistance of spheroids to hypericin PDT.
Similar articles
-
Enhancing the photodynamic effect of hypericin in human bladder transitional cell carcinoma spheroids by the use of the oxygen carrier, perfluorodecalin.Int J Oncol. 2006 Mar;28(3):775-80. Int J Oncol. 2006. PMID: 16465384
-
Enhancing the photodynamic effect of hypericin in tumour spheroids by fractionated light delivery in combination with hyperoxygenation.Int J Oncol. 2005 Jun;26(6):1691-7. Int J Oncol. 2005. PMID: 15870887
-
In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.Int J Oncol. 2001 May;18(5):1099-105. Int J Oncol. 2001. PMID: 11295062
-
Hypericin as a potential phototherapeutic agent in superficial transitional cell carcinoma of the bladder.Photochem Photobiol Sci. 2004 Aug;3(8):772-80. doi: 10.1039/b315586b. Epub 2004 Apr 2. Photochem Photobiol Sci. 2004. PMID: 15295634 Review.
-
The multifaceted photocytotoxic profile of hypericin.Mol Pharm. 2009 Nov-Dec;6(6):1775-89. doi: 10.1021/mp900166q. Mol Pharm. 2009. PMID: 19739671 Review.
Cited by
-
Accumulation and penetration behavior of hypericin in glioma tumor spheroids studied by fluorescence microscopy and confocal fluorescence lifetime imaging microscopy.Anal Bioanal Chem. 2022 Jul;414(17):4849-4860. doi: 10.1007/s00216-022-04107-2. Epub 2022 May 10. Anal Bioanal Chem. 2022. PMID: 35538227 Free PMC article.
-
Fluorescence lifetime imaging unravels the pathway of glioma cell death upon hypericin-induced photodynamic therapy.RSC Chem Biol. 2024 Oct 8;5(12):1219-31. doi: 10.1039/d4cb00107a. Online ahead of print. RSC Chem Biol. 2024. PMID: 39421718 Free PMC article.
-
Potentiality, Limitations, and Consequences of Different Experimental Models to Improve Photodynamic Therapy for Cancer Treatment in Relation to Antiangiogenic Mechanism.Cancers (Basel). 2020 Jul 30;12(8):2118. doi: 10.3390/cancers12082118. Cancers (Basel). 2020. PMID: 32751731 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources